Tag: Science and Technology

Evernorth Will Grow Accredo In Delaware

Written on . Posted in Press Releases.

Evernorth Health Services to Expand Operations in Delaware with New 200,000-Square-Foot Specialty Pharmacy and Distribution Facility

WILMINGTON, Del. –  Evernorth Health Services, The Cigna Group’s health services business, has chosen Newark, Delaware, as the location of a new approximately 200,000-square-foot specialty pharmacy and distribution facility. Within the facility, Accredo, Evernorth’s specialty pharmacy, will dispense lifesaving medications to patients across the Northeast. Additionally, Evernorth intends for its specialty pharmaceutical distributor, CuraScript SD, to operate from the facility alongside Accredo and distribute specialty medications to health care providers who treat rare and complex conditions.

The Newark, Delaware, facility will expand and replace Accredo’s existing location in New Castle, Delaware, which it has operated since 2007. The facility will be staffed by nearly 90 existing Delaware employees consisting of pharmacists, pharmacy technicians, warehouse associates, operations staff and more. Evernorth anticipates more than doubling the number of Delaware employees at the Newark facility over the next several years. These employees are dedicated to supporting patients diagnosed with some of the most rare and complex conditions known today, as well as providers who help treat these patients.

“Delaware is a health care hub for the Mid-Atlantic region. That’s one of the reasons Evernorth chose Delaware to grow their existing specialty pharmacy services and fulfillment facility,” said Governor John Carney. “We are pleased Evernorth plans to make a significant investment in the First State to expand their operations, which will enable the company to retain and add jobs over the next several years.”

“Congratulations to Accredo on their expansion in New Castle County,” said New Castle County Executive Matt Meyer. “Increasing job opportunities here in the first county in the First State is important to continue to make our state a great place to live, work and raise a family.”

Delaware Prosperity Partnership supported Evernorth’s request to Delaware’s Council on Development Finance for a Jobs Retention Grant, a Jobs Performance Grant, a Capital Expenditure Grant and a matching Training Grant.

“This new facility will help us meet the growing demand and need for specialty medications, which have risen by 280% over the past two decades,” said Matt Perlberg, President, Pharmacy, Evernorth Health Services. “Evernorth is a leader in specialty pharmacy, dispensing millions of medications to patients and providers every year. As more complex medications come to market in the years ahead, our expanding location in Delaware will enable us to more efficiently and effectively distribute these lifesaving medications to individuals throughout the country, particularly in the Northeast.”

“Delaware has been home to one of our Accredo specialty pharmacy facilities for many years, and we look forward to deepening and expanding our ties in the community as we develop our new location,” said Perlberg.

About Delaware Prosperity Partnership

Created in 2017, Delaware Prosperity Partnership (choosedelaware.com) is the nonprofit public/private organization that leads Delaware’s statewide economic development efforts to attract, grow and retain businesses; build a stronger entrepreneurial and innovation ecosystem; and support private employers in identifying, recruiting and developing talent.

About Evernorth Health Services

Evernorth Health Services creates pharmacy, care and benefits solutions to improve health and increase vitality. We relentlessly innovate to make the prediction, prevention and treatment of illness and disease more accessible to millions of people. Evernorth capabilities are powered by our businesses, including Express Scripts, Express Scripts® Pharmacy, Accredo, CuraScript SD, eviCore and MDLIVE, along with holistic Evernorth platforms and solutions that move people and organizations forward. All Evernorth solutions are serviced and provided by or through operating affiliates of Evernorth Health, a wholly owned subsidiary of The Cigna Group (NYSE: CI), or third-party partners. Learn more at evernorth.com.

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

$750M Grant Funds DE/PA/NJ Hydrogen Hub

Written on . Posted in In the News.

Mid-Atlantic Clean Hydrogen Hub Wins $750 Million Federal Grant

Delaware/Pennsylvania/New Jersey Clean Energy Collaboration Will Bring 10,000 New Jobs to Region

The Mid-Atlantic Clean Hydrogen Hub (MACH2) has been approved for $750 million in funding from the U.S. Department of Energy Regional Clean Hydrogen Hubs Program – one of just seven hubs so funded nationwide.

MACH2 aims to reduce pollution – particularly for frontline communities experiencing the “first and worst” environmental consequences – and advance clean energy. With a network of hydrogen producers, consumers and infrastructure throughout Delaware, Southeastern Pennsylvania and South Jersey, MACH2 will create more than 10,000 jobs in the production, delivery and use of zero-emission green and pink hydrogen for industrial, transportation and agricultural uses. It also will further Delaware’s prominence in the clean energy economy.

According to Delaware Governor John Carney, who co-chairs the Delaware Prosperity Partnership (DPP) Board of Directors, Delaware companies and institutions already have led on hydrogen and now will play a key role in this initiative.

Photo illustration by David Barczak

“This is a big deal,” Carney said. “Hydrogen is a clean fuel of the future, one of the ways we can pollute less. Our region has been chosen for a federal infusion of hundreds of millions of dollars that will create thousands of jobs and show how hydrogen can be made, transported and used in a real-world way. When we have talked about the opportunities for Delaware from the Bipartisan Infrastructure Law championed by President Biden and our Congressional delegation, this has been one of the big ones, and we got it. I’m looking forward to getting to work with our partners in the region.”

Dora Cheatham and the Delaware Sustainable Chemistry Association (DESCA) were among the critical organizations that spearheaded development of the winning proposal and public-private regional collaboration structures. Delaware partners – including DPP – worked alongside entities in Southeastern Pennsylvania and South Jersey on this winning plan. DPP, a proud member of the MACH2 collective, was able to financially support the more than year-long process that will have a substantive impact in Delaware and region for years to come. The October 13 announcement is another milestone in furthering DPP’s mission of advancing prosperity for all Delawareans.

“The exciting news coming from the Department of Energy about MACH2’s selection as one of our nation’s hydrogen hubs is great for the region and tremendous for the State of Delaware,” said CSC President and CEO Rod Ward, who co-chairs the DPP Board with Governor Carney. “DPP’s investment in the initiative made a lot of sense at the onset of the process. That forethought will help advance our region’s economic and environmental goals, positively impact families who live in environmentally challenged neighborhoods and provide more well-paying jobs for individuals who are part of our state’s workforce.”

The White House release about the grant awards is here. 

Additional details about MACH2 are here. 

An article about the University of Delaware’s role in the initiative is here. 

Newsletter Sign Up

Stay Up To Date With Delaware

Continue reading

DE Project Wins $3.2M NIH IDeA Grant

Written on . Posted in In the News.

National Institutes of Health awards iRED University project $3.2 million IDeA Grant

Photo Illustration by Jeffrey C. Chase/University of Delaware

DESCA, University of Delaware and InsiteHub partnership will use funding to advance biomedical entrepreneurship in Delaware

WILMINGTON, Delaware – On August 21, 2023, the National Institutes of Health (NIH) awarded a grant through the IDeA Program to iRED University – a new collaboration between DESCA, the University of Delaware and InsiteHub – that will deliver an online entrepreneurial curriculum geared to early-stage innovators and startups that will help them identify their most viable applications as early as possible and subsequently connect them to the broader innovation and mentoring ecosystem. The program is funded through a three-year grant totalling up to $3.2 million, of which more than $980,000 will be directed to DESCA. The Small Business Technology Transfer (STTR) grant is now in Phase I, with follow-on funding expected in Phase II.

According to the National Science Board 2018 Science & Engineering Indicators, university invention disclosures totaled 22,507 in 2015 (compared to 13,718 in 2003) and patent applications almost doubled over the same period. In 2016 alone, over 6,600 patents in chemistry and the sciences were awarded – yet many of these patents never realize their full commercial value. iRED University aims to change that.

The iRED University team is working on a simple premise: in order to increase the number of patents and innovations commercialized, we need to increase the funnel of viable technology startups at the front end, and in order to do that we need to meet the very specific and unique needs of technology driven innovators. iRED University will be delivered through a rigorous and engaging online curriculum that will be critical to supporting the project goals and bridging the gap of sufficient training and knowledge for innovators in the biomedical field through a high-availability on-demand learner experience platform. The curriculum will lead innovators from ideation, identifying market gaps, to execution of a product strategy that translates customer requirements into effective commercial execution of new products. The platform will also provide the ability to assess participants at the point of registration and allow them to develop and access a personalized curriculum that can be customized for their specific gaps. This helps both new and experienced innovators to focus on areas of need and provide direct learning interventions.

The product will be initially launched in Delaware and will be open to the entire Northeast when launched. The National Institutes of Health (NIH) established the IDeA (Institutional Development Award) Program in 1993 to broaden the geographic distribution of NIH funding and enhance competitiveness for funding in states with historically low NIH funding. The states that fall within the Northeast Region besides Delaware include Maine, Vermont, New Hampshire and Rhode Island. Other regions include the Southeast Region (West Virginia, Kentucky, South Carolina, Puerto Rico, Missouri), Central Region (North & South Dakota, Nebraska, Kansas, Omaha) and the Western Region (Montana, Wyoming, Idaho, Nevada, New Mexico, Alaska, Hawaii).

The core team for this new partnership includes Dr. Julius Korley, Associate VP UD Office of Economic Innovation & Partnerships (OEIP), Louis DiNetta, Technology Business Development Manager Delaware Small Business Development Center SBDC, John Royer, CEO, Insite Hub, and Dora Cheatham, Executive Director, DESCA, and combines expertise in technology development and commercialization, online curriculum development and execution, business development and new product commercialization and SBIR/STTR expertise.

About DESCA

Formed in 2010, the mission of DESCA is to enable science innovators commercialize their technologies faster, as well as driving the new legacy of ChemTech. Today, DESCA has 3 key areas of focus around which it builds its programming:

    • Driving innovation and collaborative partnerships between major strategics, startups and universities;
    • Convening industry leaders in the public and private sectors on emerging issues and driving adoption of emerging trends & technologies that will be the key drivers of sustainability for the future;
    • Connecting students to industry and vice versa, with a goal of harmonizing the development of talent with the validated needs of industry.

    About OEIP

    The Office of Economic Innovations and Partnerships brings together the collective and integrated resources of the University of Delaware and the State’s business, academic and entrepreneurial communities to achieve new levels of innovation and economic development. The Office strives to:

    • Be the partner of choice in matters of economic development, commercialization of innovation, entrepreneurship and building businesses;
    • Enable entrepreneurs and innovators to accelerate ideas into the marketplace, grow businesses and form partnerships through access to University assets, space, capital, counsel and connections;
    • Deliver a unique, integrated model centered on long term, productive partnerships.
    • Support the University, state and region’s entrepreneurial, technical and business communities to reach new levels of economic development.
    • Create a culture where ideas and innovation thrive.

      About INSITE HUB

      • InsiteHub has been a provider of learning technology, medical education, and product training to the life science and medical device industries for over 10 years. InsiteHub has established itself as a leader by developing innovative learning technology solutions and earning key industry awards for application design and impact. In addition, InsiteHub’s platform was featured in an extensive Department of Education grant focused on researching student engagement at the university level. InsiteHubs’s instructional design paradigm is based on the ADDIE model whose steps include Analysis, Design, Development, Implementation, and Evaluation.

      About Delaware SBDC

      • For over 35 years, the “T” accredited DSBDC has assisted Delaware’s small businesses through information, counseling, and education. DSBDC’s technical assistance has resulted in more than 1,500+ new business starts, 4,200+ new jobs created (since inception), and $267M capital raised (since 2010). In 2009, DSBDC became only the eighth SBDC accredited as a “technology” designated program after demonstrating significant efforts to target and support Delaware’s technology-based businesses as well as its pivotal role as an essential connector and resource within the state’s entrepreneurial and technology ecosystems.

      This article was originally posted on the Delaware Sustainable Chemistry Alliance website at: https://desca.net/f/desca-ud-insite-hub-win-3m-grant-to-advance-entrepreneurship

      Newsletter Sign Up

      Stay Up To Date With Delaware

      Continue reading

      Patrick Callahan of LabWare

      Written on . Posted in Success Stories.

      Entrepreneur Patrick Callahan, Head of Data and Analytics for LabWare

      An Ongoing Series Highlighting Delaware Innovators

      LabWare’s acquisition of Patrick Callahan’s CompassRed data analytics firm in February 2022 started with a chance first encounter between Callahan and LabWare President and CEO Vance Kershner and Callahan at Buckley’s Tavern in Centreville.

      “Developing a relationship with Vance is the perfect example of things that happen in Delaware that just don’t happen anywhere else, in my opinion,” Callahan said. “We met over a bar stool.”

      Callahan built CompassRed into a visionary company in machine learning and predictive analytics. As head of data and analytics at LabWare, he is now developing a dedicated advanced data analytic arm as part of efforts to elevate the company’s position as the global leader in the laboratory information management market.

      Previously, the Drexel University and Widener School of Law graduate was a founding partner of The Archer Group. The award-winning, interactive internet marketing firm, founded in 2003, serves a diverse roster of clients in the financial services, retail, pharmaceutical and entertainment industries – including numerous Fortune 500 clients.

      Callahan also serves on the boards of several Delaware organizations. These include the Delaware Data Innovation Lab, the Pete du Pont Freedom Foundation, Girls on the Run and Delaware Prosperity Partnership.

      He spoke with DPP about innovation in Delaware and what it takes to innovate successfully.

      Why is Delaware a great state to be an innovator?

      I’m sure we’ve heard this a million times, but the accessibility to me is the big thing. If you’re looking to be in one of the best labs or chemical spaces, you can drive 40 feet and find people who are customers, thinkers, funders and legislators. There’s a reason why we have the biggest banking, biggest chemical companies and a lot of the other things right here in the Northeast corridor. When people talk about what made the country great, you can see that diversity here in the state – socioeconomic levels, education levels, diversity of thoughts and backgrounds.

      How I met Vance is a great example. You couldn’t just go to San Francisco and get a meeting with founders like Reid Hoffman (LinkedIn), Mark Zuckerberg (Facebook) or Marc Andreessen (Mosaic, Netscape). You just don’t go to a restaurant, introduce yourself and then strike up a conversation there. That’s unheard of.

      In your view, what qualities should a successful innovator have?

      I think humility is one thing. If you’re humble, that means you’re always learning, you’re always trying to figure out things, and you’re always knowing you don’t have the answer. People who say, “I know the answer,” are the ones who nine times out of 10, don’t. Getting out there and meeting people is very, very important if you want to sell your product or address the problem that you’re trying to address. That could be over Zoom or in person, but curiosity about another person’s view and experiences is just so important. Expanding what we’re doing at LabWare requires me to get to know the customers in the labs and the end user of the product.

      Intellectual curiosity and the willingness to listen to someone no matter how different they are is something you can learn and build into your product and innovate.

      You can do that over Zoom. We’ve shown over the last two years that’s essential, and maybe even easier. Before COVID, we’d have meetups where only 30 or 40 people would show up in person. But during COVID, we’d get hundreds of people from all around the world, which would lead to follow-up calls. I don’t know if we’ll go back. We want to have a mixture of both because there are things you can learn on the side before the meeting.

      What advice would you give an innovator who’s just starting?

      First, go meet people, go to these meetups. Many are free, but I find myself asking if someone will spend $1 on it. To me, that is a good qualifier because if you give it to them for free, they won’t necessarily assign value to it. When we were doing these meetups, people would sign up but two-thirds of them wouldn’t show up. The minute we started charging $5 and giving the money away to a nonprofit, really engaged people showed up because they thought of it as value. If you’re providing value, you should get value back for it. It’s not just time.

      Second, follow your interest. Doing good is good for business. I feel passionate about Girls on the Run, but speaking at a networking event also landed Archer one of our largest clients. Don’t go into it thinking you’re going to get something out of it. Be genuine, but give back to the community – and encourage your team to do the same — and I’ll tell you, you’ll get it back tenfold. There are so many nonprofits in Delaware that do so many good things that you’ll meet your next customer, hear about the next important problem that you can help solve or just meet someone with a different perspective that will help you back at the office.

      Newsletter Sign Up

      Stay Up To Date With Delaware

      Continue reading

      Jalaal Hayes, Ph.D., Founder of Elyte Energy

      Written on . Posted in Success Stories.

      An Ongoing Series Highlighting Delaware Innovators

      At 22, Dr. Jalaal Hayes made Delaware State University (DSU) history as its youngest doctoral degree candidate. The native of North Philadelphia earned this honor in 2015 by successfully defending his thesis “Thermodynamic and Kinetic Studies of Alkali-Metal Doped Lithium Amide-Magnesium Hydride Hydrogen Storage System.”

      He then taught in Philadelphia for the Universal Companies and Cristo Rey Philadelphia High School for nearly two years in pursuit of his teaching mission to make science, technology, engineering, arts and mathematics (STEAM) simple. He spent the following two years as a visiting assistant professor of physical chemistry at DSU and then was an assistant professor of chemistry at Lincoln University for almost four years.

      In 2020, Hayes founded Elyte Energy, a Dover, Delaware-based clean-energy company that uses patent-protected hydrogen technology to build a highly efficient power supply for fixed and portable devices. The startup won an Encouraging Development, Growth and Expansion (EDGE) Grant from the Delaware Division of Small Business in 2021. The grant helped fund laboratory space and equipment to develop a commercial prototype of Elyte’s hydrogen-based system, and the technology has application in the greater global vehicle market.

      Dr. Jalaal Hayes, second from left, accepted a 2021 EDGE Grant for Elyte Energy during a ceremony with Governor John Carney in 2021.

      Hayes previously founded Elyte Universal Network, a STEAM-based content entity that focuses on making difficult and complex sciences simple and accessible to all communities. He also has authored two books and spoken at numerous events, including TEDxWilmingtonSalon, delivering “The Chemistry of Community Building,” and the Innovative Applied Energy Conference held at the University of Oxford in England. In addition, he released a documentary about his journey to becoming the youngest applied chemistry Ph.D. candidate in America called “Exploding Dreams: A STEAM Story” in 2021.

      Speaking with Delaware Prosperity Partnership, Hayes shared his views on innovation in Delaware along with advice he’d give to hungry innovators.

      Why is Delaware a great state to be an innovator?

      Due to the state’s cost-effective living and growth potential, economically and socially, Delaware is a great state to innovate, communicate and elevate the status quo of the country for generations to come.

      In your view, what qualities should a successful innovator have?

      Excellent communication skills, the ability to see and create the future and the ability to provide solutions and opportunities to their respective industries and communities – financially, socially, etc. Along with these qualities, you must be resilient and willing to learn and apply lessons fast in every trial and tribulation that comes your way that tries to block you from achieving your minimum viable product or even that first contract to pay for your idea. In addition to the qualities above, production, quality and speed are the keys to innovation, especially in our current times.

      What advice would you give innovators just starting?

      When discussing your innovation, be clear and concise on how your technology or idea can apply to specific problems and make things easier, better, faster or cost-effective for the overall “big picture.” For innovators just starting, draw or write out your idea and ask people if they would buy into it and why. You can start with friends, but you’ll need to ask outside your trusted group. If there’s a positive response, go for it and begin to build the most cost-effective product possible. Get a team or expert advisors to assist with every checkpoint along the journey. In addition, it helps to constantly check your technology readiness level for your technology as you gain more information and new results from each experiment and iteration.

      How do you decide whether a new idea is worth pursuing or should be set aside?

      You need to ask the following questions:

      • Is it the right time to solve this problem?
      • How many people can buy into the idea? Is it greater than 100 people? If so, go for it. If not, what is next?
      • Are you willing to disrupt the status quo for the greater good?

      Once you answer these questions and the answers indicate that you are ready to move forward, begin setting up SMART (specific, measurable, achievable, relevant and time-bound) goals for the development of the project.

      Newsletter Sign Up

      Stay Up To Date With Delaware

      Continue reading

      Agilent Investing $22M in Delaware Site

      Written on . Posted in Press Releases.

      Agilent Chooses Delaware for $22M Investment in Manufacturing to Meet Growing Demand for Biopharma Consumables

      Investment in Newport facility will support economic and job growth over next decade

      WILMINGTON, Del. – Agilent Technologies Inc., a global leader in analytical instrumentation development and manufacturing and one of Delaware’s largest private-sector employers, has chosen to modernize and expand its Newport, Delaware, manufacturing facility to meet growing global demand for its biopharma consumables.

      Agilent plans to invest nearly $22 million to increase the capacity of its lab-based manufacturing site in Newport, leasing 12,000 square feet adjacent to its existing facility and fitting out 9,900 square feet as lab space with new infrastructure, equipment and instrumentation. Over half of the remaining square footage will become a warehouse, storage and shipping/receiving area, and the balance will be used for offices.

      This latest expansion follows another investment by Agilent last year to its Wilmington-area Little Falls R&D labs. Agilent employs 18,000 people worldwide, including more than 950 in Delaware. The Newport site employs 110 workers, and the expansion is expected to create additional new jobs over the next 10 years.

      “Delaware has a strong manufacturing history, and this latest investment by Agilent Technologies confirms the company’s commitment to innovating in the First State,” said Governor John Carney. “We are pleased Agilent will be expanding and bringing more good-paying jobs to the state’s strong science, technology and biopharmaceutical sectors.”

      The Newport facility, one of several Agilent manufacturing sites across the United States, produces liquid chromatography columns used for chemical and biochemical analysis, drug discovery, environmental control and analytical chemistry. Growing worldwide demand for these analytical consumables led the company to review its U.S. facilities to determine the best opportunity to grow production capacity. Agilent’s decision to invest in its Newport site in New Castle County reflects confidence in Delaware’s dynamic business environment and the large pool of regional talent.

      “Agilent’s latest expansion is proof that New Castle County is a great place to create and grow your business,” said New Castle County Executive Matt Meyer. “It’s become well known that we have the resources and the talent to continue to be a leader in the chemical and biopharma industry.”

      DPP’s Noah Olson, left, and Megan Kopistecki, joined Agilent Technologies Manufacturing Site Manager Graham Margetts, center, in presenting to the Delaware Council on Development Finance.

      DPP’s Noah Olson, left, and Megan Kopistecki, joined Agilent Technologies Manufacturing Site Manager Graham Margetts, center, in presenting to the Delaware Council on Development Finance.

      Delaware Prosperity Partnership has been engaged with Agilent as the company explored growth possibilities in Delaware. Today, DPP supported Agilent’s request to the Council on Development Finance for a Delaware Graduated Lab Space Grant of up to $693,000 from the Delaware Strategic Fund. Distribution of grants from the Delaware Strategic Fund are dependent on the company meeting commitments as outlined to the CDF, which reviewed and approved Agilent’s request.

      “Agilent has been operating in Delaware for more than 20 years, and we are pleased to continue investing in our manufacturing and R&D facilities in the First State,” said Henrik Ancher-Jensen, Agilent’s Order Fulfillment and Supply Chain president. “We are honored to be part of this dynamic community that supports innovation and growth and attracts top talent.”

      ###

      About Delaware Prosperity Partnership

      Created in 2017, Delaware Prosperity Partnership (choosedelaware.com) is the nonprofit public/private organization that leads Delaware’s statewide economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support private employers in identifying, recruiting and developing talent.

      About Agilent Technologies

      Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services and expertise that provide trusted answers to customers’ most challenging questions. The company generated revenue of $6.85 billion in fiscal 2022 and employs 18,000 people worldwide. More information about Agilent is available at agilent.com.

      Newsletter Sign Up

      Stay Up To Date With Delaware

      Continue reading

      DTP Hub to Grow Delaware Life Sciences

      Written on . Posted in In the News.

      Photo courtesy of South Duvall

      LIFE SCIENCE SYNERGY

      New facility at the Delaware Technology Park has major potential for UD and Delaware

      For more than 20 years, the Delaware Technology Park (DTP) in Newark has been one of the state’s main economic drivers, bringing jobs in research and development and helping to educate and train future innovators through synergy and partnerships with the University of Delaware.

      The park will build on that rich history of success on the eastern edge of the UD campus by leasing out the final parcel for construction of a three-story, 100,000-square-foot facility that aims to become a hub for life science and research companies. In addition, it could potentially provide wet-lab space for commercial spinouts from the University.

      “The life sciences community continues to grow in Delaware and the region, with UD contributing critical research, innovation and workforce development,” UD President Dennis Assanis said. “Our previous partnerships with DTP companies have yielded outstanding opportunities for students, such as internships, guest lectures and employment. We anticipate that the companies in this new facility will open new avenues for federally funded research collaborations with UD’s faculty and research centers.”

      The developer, Rockville, Maryland-based South Duvall, has signed an agreement to begin construction on the last remaining parcel — a nearly seven-acre piece of land fronting Wyoming Road. The property’s adjacency to UD was a major factor for the company, said Robert Scheer, South Duvall’s president and a life science real estate industry veteran. Among the reasons for his excitement: the University’s elite engineering programs, the potential to house UD facilities and that university research parks have proven to be dynamic spaces for growth across the country.

      “We are excited to play a role in the next stage of the Delaware Technology Park’s growth,” Scheer said. “An impressive ecosystem has been built in Newark and this building will foster continued growth in Delaware’s life science community.”

      Mike Bowman, president and CEO of DTP, said its management and board have wanted to fill the remaining parcel with a signature multi-tenant life science building for a while, but have been waiting for the right market conditions.

      “That time has arrived,” Bowman said. “Several local companies are seeking to expand, and new ones are interested in coming to Delaware. The proximity to UD is vital for tenants to collaborate with UD’s facilities, research talent and future workforce.”

      Like the other five buildings at the technology park, the new facility will have a multitude of benefits for UD and its faculty and students.

      Bringing more companies close to campus provides students — especially those who don’t have access to private transportation — the ability to take advantage of experiential learning and employment. Also, DTP@STAR, the incubator on STAR Campus, has limited space and is best suited for very small businesses. The new building will enable growth for these and other companies and encourage job retention in Delaware.

      South Duvall officials expect to bring in the first of its tenants — which will join 10 others at Innovation Way — at some point in 2025.

      Kurt Foreman, president and CEO of the Delaware Prosperity Partnership (DPP), lauded the University, Delaware Technology Park and South Duvall for their efforts, which will further DPP’s mission to attract, grow and retain businesses in Delaware.

      “Increasing Delaware’s inventory of affordable, high-quality lab space invites companies from both within and outside the state to choose to grow here will support Delaware’s continued momentum in life sciences and other lab-based fields,” said Kurt Foreman, president and CEO of Delaware Prosperity Partnership. “DPP appreciates DTP’s decades of leadership in promoting the long-term growth of Delaware’s science and technology sector through projects like this and welcomes South Duvall’s recent engagement that will bring their considerable industry expertise to our state’s innovation ecosystem.”

      This article by Peter Bothum was originally posted by the University of Delaware at: https://www.udel.edu/udaily/2023/june/science-research-technology/

      Newsletter Sign Up

      Stay Up To Date With Delaware

      Continue reading

      global water tech company expands in Delaware

      Global Water Tech Leader Expands in Delaware

      Written on . Posted in Press Releases.

      Global Water Technologies Leader Solenis Chooses Delaware for $40M Expansion

      Growth in Wilmington Driven by Increasing Market Demand for Company’s Sustainability-focused Products and Expertise

      WILMINGTON, Del. — Delaware-based global water technologies leader Solenis has chosen its hometown of Wilmington as the site for a $40 million research and development expansion.

      In response to increasing market demand for its sustainability-focused products and expertise and with an eye toward long-term growth, Solenis will expand its R&D operations with a move to the 100,000-square-foot Building 713 at Chestnut Run Innovation and Science Park (CRISP). CRISP is a former DuPont campus that MRA Group is developing into a hub for a range of life sciences and advanced chemical companies.

      Solenis is a global leader in supplying innovative specialty chemicals and services for process, functional, and water treatment applications to consumer and industrial markets.

      The new CRISP facility will provide Solenis with 20,000 square feet more lab space than the company currently has at its existing R&D center on Ashland’s Wilmington campus. In addition to more space, the larger, upgraded site will allow Solenis to add up to 46 new highly skilled Delaware jobs — including lab technicians, scientists and R&D supervisors — within the next three years.

      “Solenis chose to build their global water technologies in Wilmington. This week’s announcement shows their continued commitment to our state and workforce,” said Governor John Carney. “Solenis will expand its research and development operations to a 100,000-square-foot building. Thank you to Solenis for continuing to strengthen Delaware’s workforce and science and technology sector.”

      Solenis is a vital part of Delaware’s science and technology sector and is a significant Delaware employer. Choosing to invest in a new facility in Wilmington will provide Solenis with the opportunity to grow its R&D team to support projected growth while solidifying its commitment to Delaware.

      Originally spun off from Ashland and headquartered at Wilmington’s Avenue North since 2020, Solenis has 48 manufacturing facilities and more than 6,400 employees around the world to serve an array of industries in 120 countries. Solenis currently employs more than 300 in Delaware, with approximately 185 employees at the Avenue North headquarters and 140 employees at its Ashland R&D site. Both are located in Northern Delaware’s New Castle County.

      “What the MRA Group has done for the CRISP campus is transformative for our County,” said New Castle County Executive Matt Meyer. “The redeveloped campus gives our existing Delaware companies that are expanding a home to grow and thrive. New Castle County is proud to continue to be the home of Solenis, which provides great jobs in our community producing innovative and sustainable solutions for everyday life.”

      Solenis officials presented an application to Delaware’s Council on Development Finance (CDF) for a Jobs Performance Grant of $552,000 and a Delaware Lab Space Grant of $3.5 million from the Delaware Strategic Fund to support the company’s investment of $40 million. Distribution of grants from the Delaware Strategic Fund are dependent on the company meeting commitments as outlined to the CDF, which reviewed and approved the Solenis team’s request for up to $4.052 million in total grant funding.

      “Solenis has deep roots in Delaware, so we are pleased to announce our continued commitment to growing in the state at CRISP,” said John Panichella, CEO, Solenis. “This investment of moving our Wilmington research center to a contemporary new location, in combination with our recently opened headquarters at Avenue North, allows us to continue to attract, retain and recruit the highest caliber of employees.”

      ###

      About Delaware Prosperity Partnership

      Delaware Prosperity Partnership leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support employers in place marketing Delaware to potential employees via livelovedelaware.com. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

      About Solenis

      Solenis is a leading global producer of specialty chemicals focused on delivering sustainable solutions for water-intensive industries, including the pulp, packaging paper and board, tissue and towel, oil and gas, petroleum refining, chemical processing, mining, biorefining, power, municipal, and pool and spa markets. Owned by Platinum Equity, the company’s product portfolio includes a broad array of water treatment chemistries, process aids and functional additives, as well as state-of-the-art monitoring and control systems. These technologies are used by customers to improve operational efficiencies, enhance product quality, protect plant assets, minimize environmental impact and maintain healthy water. Headquartered in Wilmington, Delaware, the company has 48 manufacturing facilities strategically located around the globe and employs a team of over 6,400 professionals in 120 countries across five continents. Solenis is a 2022 US Best Managed Company. For additional information about Solenis, please visit www.solenis.com or follow us on social media.

      Newsletter Sign Up

      Stay Up To Date With Delaware

      Continue reading

      biopharma company uvax bio expands in Delaware

      Biopharma Company Uvax Bio Chooses Delaware

      Written on . Posted in Press Releases.

      Early-Stage Biopharma Company Uvax Bio Chooses Delaware for $8M Investment in Next Level of Growth

      Expansion of vaccine research, development and commercialization operations bringing 63 new jobs to Newark over next three years

      WILMINGTON, Del. – Uvax Bio LLC, an early-stage biopharmaceutical company with cutting-edge vaccine platform technology that has produced both COVID-19 and HIV-1 vaccine candidates, has chosen to grow in Newark, Delaware, where it has been headquartered since forming in 2018.

      As part of its expansion, Uvax Bio plans to add 63 employees to its current five-member team. Positions will range from research associates to executive-level research directors with minimum salaries ranging from $45,000 to more than $130,000.

      “Uvax Bio LLC is an innovative company in the science and technology sector, specializing in vaccine platform technology. Today’s announcement to grow in Newark shows their continued commitment to our state and workforce,” said Governor John Carney. “Uvax Bio plans to increase their employees tenfold with this expansion. Thank you to Uvax Bio for their commitment to Delaware’s rapidly growing life sciences sector.”

      To accommodate its next level of growth, the company has relocated to 100 Biddle Avenue in Springside Plaza off Route 40. Plans there include renovating the site’s existing wet lab and office space into a facility ideal for achieving the company’s goal of developing vaccines that support public health and improve life.

      Uvax Bio is an innovative part of Delaware’s rapidly growing life sciences sector. The company maintains vital partnerships with Newark-based, internationally known industry players such as the National Institute for Innovation in Manufacturing Biopharmaceuticals and the University of Delaware.

      “New Castle County is proud to be home of another life sciences company that is providing life-changing vaccines for the world,” said New Castle County Executive Matt Meyer. “Uvax is a great example of when science and innovation merge into solutions that will save lives.”

      Uvax Bio was formed to develop and commercialize next-generation vaccines to address infectious diseases that threaten global health. Uvax Bio holds an exclusive license agreement with California-based nonprofit biomedical research facility Scripps Research that covers 11 patented and proprietary 1c-SApNP® vaccines. The company’s platform technology is based on computational biology and rational design. These cutting-edge scientific tools were used to design the Uvax, an all-in-one, viruslike nanoparticle design and a one-for-all, simple manufacturing process invented by Uvax Bio co-founder and Chief Scientific Officer Jiang Zhu, Professor of Scripps Research.

      The opportunity for Uvax Bio to take their two lead vaccine candidates for COVID-19 and HIV-1 into Phase 1 trials represents a major milestone for the company. While the company’s two lead candidates are entering human trials, Uvax plans to raise additional capital in order to advance other promising new vaccine candidates toward Phase 1 readiness.

      During today’s meeting of Delaware’s Council on Development Finance, Uvax Bio officials presented an application for a Jobs Performance Grant of up to $1,061,955 and a Capital Expenditures Grant of up to $240,000 from the Delaware Strategic Fund. Distribution of grants from the Delaware Strategic Fund are dependent on the company meeting commitments as outlined to the CDF, which reviewed and approved Uvax Bio’s request for up to $1,301,955 in total grant funding.

      “The team at Uvax Bio is passionate about our mission to design and deliver groundbreaking vaccines to address global threats from infectious disease,” said Ji Li, Ph.D., Uvax CEO. “We are very excited to build a team of talented scientific, business and administrative professionals right here in the Newark, Delaware, area!”

      ###

      About Delaware Prosperity Partnership

      Delaware Prosperity Partnership (choosedelaware.com) leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support employers in place marketing Delaware to potential employees via livelovedelaware.com. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

      About Uvax Bio

      Founded in early 2018, Uvax Bio, a spinoff vaccine company from Scripps Research, employs proprietary 1c-SApNP® platform technology developed by Dr. Jiang Zhu of Scripps Research to develop and commercialize prophylactic vaccines for the most challenging infectious diseases. Uvax Bio’s mission is working to solve the world’s infectious disease threats by combining rational antigen design and protein engineering to create viruslike particle vaccines. Its vision is to become a global leader in the vaccine industry and offer vaccine solutions for unmet public health needs.

      Kurt Foreman

      PRESIDENT & CEO

      Newsletter Sign Up

      Stay Up To Date With Delaware

      Continue reading

      The Royale Group speciality chemical companies Delaware

      Royale Group Expanding to 2nd Delaware Site

      Written on . Posted in Press Releases.

      Royale Group Expanding to Second Delaware Location

      August 22, 2022 – 

      Company adding Royale Pigments & Chemicals site in Seaford to AWSM Solutions Delaware site in Bear, doubling its Delaware presence in just two years.

      (WILMINGTON, Del.) – Royale Pigments & Chemicals, part of The Royale Group collection of specialty chemical companies, has chosen Seaford, Delaware, as the site for a $2.35 million expansion that will double The Royale Group’s Delaware presence since it relocated from New Jersey two years ago.

      Royale’s investment in Sussex County includes purchase of the former BASF Polymer Plant at 100 Industrial Park Boulevard that is now owned by Delmarva Central Railroad. DCR operates a transloading facility at the on-site rail spur located there, but the building itself is underutilized with no active operations at present.

      “The chemical industry has long been part of Delaware’s economy. Over the next three years, The Royale Group plans to purchase an underutilized site in Seaford, bringing new jobs and economic growth to Sussex County,” said Governor John Carney. “This will be Royale’s second facility in the state, showing their commitment to growing their business here. This campus is only possible because of Delaware’s world-class innovative workforce. Thank you to The Royale Group, the town of Seaford, the Delaware Prosperity Partnership and everyone else who made this acquisition possible.”

      In 2020, Delaware Prosperity Partnership began working with The Royale Group as it made its first investment in Delaware by acquiring IMS Chemblend and the IMS facility at 400 Carson Drive in Bear, changing the operation’s name to AWSM Solutions Delaware and relocating Royale’s corporate headquarters from New Jersey to the New Castle County property. The company’s $1 million investment included adding 17 new jobs, and AWSM already has surpassed its job-growth projections with 30 active employees.

      While continuing to invest and grow its Northern Delaware operations, Royale’s expansion to a second Delaware location with on-site rail access will allow it to better serve a growing roster of customers and secure new contracts with leading companies throughout the region. Royale’s Southern Delaware investment includes creating 29 new jobs – including chemical operator, maintenance/warehouse and manager/supervisor positions – over the next three years. 

      Royale officials presented an application to Delaware’s Council on Development Finance for a Jobs Performance Grant of $177,930 and a Capital Expenditure Grant of $70,500 from the Delaware Strategic Fund to support the company’s investment of more than $2.35 million. Distribution of grants from the Delaware Strategic Fund are dependent on the company meeting commitments as outlined to the CDF, which reviewed and approved Royale’s request for up to $248,430 in total grant funding.

       “We are very excited to welcome Royale Pigments & Chemicals to Seaford, Delaware,” said Seaford Mayor David Genshaw. “Our city has seen an incredible wave of revitalization with the help of Delaware Prosperity Partnership, and we are grateful for their support and for Royale Pigments & Chemicals for choosing Seaford.” 

      The Royale Group was drawn to establish operations in Delaware by the state’s educated workforce, lower cost of living and business-friendly government. Royale has quickly become an important part of Delaware’s chemical manufacturing and distribution sector, and its decision to invest in a second Delaware facility demonstrates its continued commitment to growing here.

      “Delaware has been a great place to do business! There are many valuable resources to help start or move a business to the state,” said Royale Group CEO John Logue. “These resources range from the Delaware Prosperity Partnership to a dedicated and assigned omnibus person from the Delaware Department of Natural Resources and Environmental Control, providing assistance with Delaware’s regulatory agency. We are excited with the expansion of our manufacturing operation in Delaware.”

      ###

       About Delaware Prosperity Partnership

      Delaware Prosperity Partnership (choosedelaware.com) leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support  employers in place marketing Delaware to potential employees via livelovedelaware.com. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

       About The Royale Group

      The Royale Group, recipient of the 2019 National Association of Chemical Distributors’ prestigious Distributor of the Year award, is a collection of specialty chemical companies that manufactures, formulates and distributes chemicals. Specifically, Royale Pigments & Chemicals distributes specialty colorants into the paint, coatings and fire retardants markets. Shorechem distributes and manufactures specialty chemicals into the pharma, metals, aerospace and automotive markets. AWSM Industries distributes and manufactures specialty chemicals into the chip fabrication, automotive and gas markets. Most recently acquired in 2020, AWSM Solutions toll manufactures, blends, formulates, breaks bulk packages and provides labels for products in the following markets: organic agrochem, pharma, electronics, cleaners, aerospace, marine and construction.

      Newsletter Sign Up

      Stay Up To Date With Delaware

      Continue reading

      Versogen chooses Delaware

      Versogen Chooses Delaware for Expansion

      Written on . Posted in Press Releases.

      WILMINGTON, Del. – Versogen, an industry-leading green energy startup, has chosen Delaware as the site for a $4.8 million expansion that includes moving its operations from The Innovation Space in Wilmington, Delaware, to larger, upgraded facilities at FMC Stine Research Center in Newark, Delaware.

      Versogen targets deep decarbonization of the sectors of our economy that are not possible by green electricity. The startup is focused on anion-exchange membranes (AEMs) and AEM based electrolyzers to produce low-cost green hydrogen at scale. The company’s systems are engineered to make green hydrogen affordable and sustainable – from the materials used in manufacturing through to the costs of operations.

      “Delaware has been a hub for innovation for decades. Versogen is the latest success out of Delaware’s Innovation Space and a great example of the collaborative environment we have for economic development in our state,” said Governor John Carney. “We are excited for Versogen’s expansion, bringing new jobs and important technologies to New Castle County.”

      Versogen’s investment includes renovating Stine Building 115 and creating additional lab space at the site, which will be fully operational by 2024. The company’s relocation will accommodate its next level of operations, which includes adding forty-nine new jobs over the next three years to the 16 positions currently staffing the company.

      “New Castle County is the ideal place for startup companies like Versogen to create innovative green technologies,” said New Castle County Executive Matt Meyer. “We are proud to welcome Versogen and know that it will find the first-rate talent for employees and further growth.”

      Officials from FMC agreed.

      “At the FMC Stine Research Center, we work hard to change the world for the better,” said Dr. Kathleen Shelton, FMC executive vice president and chief technology officer. “We are excited to welcome Versogen and applaud them for developing industry-leading green energy technologies. We appreciate Delaware Prosperity Partnership for the continued collaboration and actively building a strong entrepreneurial and innovation ecosystem in the State of Delaware.”

      Versogen officials presented today to Delaware’s Council on Development Finance the company’s application for a Delaware Lab Space Grant of $450,380 and a Jobs Performance Grant of $151,343 from the Delaware Strategic Fund to support the company’s investment of more than $4.8 million. Distribution of grants from the Delaware Strategic Fund are dependent on the company meeting commitments as outlined to the CDF, which reviewed and approved Versogen’s request for up to $601,723 in total grant funding.

      “Versogen has been strongly supported by the State of Delaware directly or indirectly from its inception,” said Yushan Yan, Versogen co-founder and CEO. “The grants approved today for Versogen from the Delaware Strategic Fund demonstrate Delaware’s unwavering commitment to building a vibrant entrepreneurial environment for startups and to providing critically needed facilities grants for them to grow.”

      Versogen began with research conducted in Yan’s lab in his role as Henry B. du Pont Chair of Chemical and Biomolecular Engineering at the University of Delaware. As Yan said, Delaware recognized the startup’s promise right away. So did entities throughout the United States, with numerous supporting the company’s work to bring to market a new class of polymer membranes that will make green hydrogen and fuel cells more economical.

      Originally branded as W7 Energy and rebranded as Versogen in 2021, the company has been supported by more than $5 million in grants. These include the prestigious BIRD Project grant in 2020 and selection as one of three startups for the fourth cohort of the Shell GameChanger Accelerator (GCxN) program in 2021.

      Earlier this year, Versogen closed a Series A funding round that raised $14.5 million. This investment allows the company to scale development of its low-cost green hydrogen electrolyzer stacks.

      ###

      About Delaware Prosperity Partnership

      Delaware Prosperity Partnership leads Delaware’s economic development efforts to attract, grow and retain businesses; to build a stronger entrepreneurial and innovation ecosystem; and to support employers in place marketing Delaware to potential employees via livelovedelaware.com. The DPP team works with site selectors, executives and developers focused on where to locate or grow a business and helps with reviewing potential sites, cost-of-living analyses and funding opportunities, including available tax credits and incentives. DPP advances a culture of innovation in Delaware, working with innovators and startups to spotlight and celebrate successes and connect them with the resources they need to succeed. DPP and its partnerships throughout Delaware support and advance the missions of companies of all sizes and sectors.

      About Versogen

      Versogen is an industry-leading green energy startup founded by Yushan Yan, the Henry B. du Pont Chair of Chemical and Biomolecular Engineering at the University of Delaware and a member of the National Academy of Engineering. The company’s focus is decarbonizing heavy, hard-to-abate carbon by producing low-cost green hydrogen with its zero-emission AEM electrolyzer that uses natural materials, water and renewable energy to produce hydrogen at scale. Versogen systems are engineered to make green hydrogen affordable and sustainable – from the materials used in manufacturing right through to the costs of operations.

      Newsletter Sign Up

      Stay Up To Date With Delaware

      Continue reading

      carbon-capture technology in Delaware

      Nemser Team Tackles Carbon-Capture in Plants

      Written on . Posted in Success Stories.

      Delaware Firm Focuses on Low-cost Carbon Capture Technology

      When people talk about climate change, they usually focus on behavior change, clean electricity, driving electric cars and using wind and solar power. But Compact Membrane Systems (CMS) CEO Erica Nemser focuses on carbon capture — reducing emissions from the production of things that we want and need: steel for buildings; plastic production for cars, buildings, and medical equipment; and cement for roads.

      A pioneer in separations technology, New Castle-based CMS has launched a long-awaited pilot demonstration of its proprietary Optiperm membrane technology at Braskem’s Marcus Hook petrochemicals facility, laying the groundwork for broader application of its low-cost carbon-capture technology.

      “I tell people I work in the planet-friendly, sustainable chemistry space,” Nemser says. “It’s really difficult to move production of the things we depend on every day to clean electricity, so we’re capturing the CO2 (carbon dioxide) produced from those processes before it leaves the smokestack. We’re concentrating that CO2 so that it can be used or sequestered underground, leading to more products and fewer emissions.”

      “I don’t think anyone really wants a solution where we have to say no to steel and cement and some of the things that enable us to live the kind of lives we live and develop the medicines and the healthcare and other materials that we use,” she says.

      That’s her pitch to the layman, but when Nemser talks to prospective investors or users of her carbon-capturing membranes, they understand the benefits for hard-to-abate industries but want to know what makes CMS special.

      The company’s Optiperm technology uses membranes to separate the gases used to create plastics (olefins) from fuels (paraffins). Industry journals have described CMS’s efforts to develop membranes with commercial applications as a process improvement that could “change the world [and] reap great global benefits” through heightened energy efficiency.

      Nemser says CMS is a leader in offering membrane technologies for carbon capture.

      “There’s an existing commercial technology for carbon capture now; it’s just expensive and difficult to use in a range of applications,” she says. “Many new developments are still [in the lab] and face many technology risks. We’re far, far ahead of those. We believe Optiperm offers benefits from a cost and ease-of-use standpoint and can address the needs of customers that want a carbon capture system — steam methane reformers, plants making blue hydrogen, and steel plants and cement plants.

      “At the end of the day, keeping the cost low is important because the CO2 is essentially an emission stream that nobody wants, so they want to do it as inexpensively as possible. We can make applications of all sizes under their operating conditions. Others in our business can’t say that.”

      Nemser says CMS has two customers — manufacturing plants…and the planet. Optiperm will help manufacturers meet goals tied to the Paris accords (and others) to reduce their greenhouse gas emissions and reduce their CO2 footprint over different timelines ranging from 2025 to 2050. Other prospective partners already have underground carbon-capture facilities and need partners like CMS to serve those customers at a more reasonable price.

      As for the planet, she says “every molecule of CO2 that we take out of a smokestack and avoid going into the environment is a net gain.”

      The Optiperm project with Braskem is the largest demonstration yet of its membrane doing a separation. A scaled-down version of the commercial system that CMS can deliver today, it’s a 500-day project that is already generating data that has the CMS team excited about hitting all its goals.

      “We’ll get a lot of data over the next 18 months or so, but we believe we’ll be able to prove what our technology can offer well before that,” Nemser says. “This is not a science project confined to a lab. It’s a significant technology validation and proof point for investors and partners. We’ll be showing them this technology works at a commercial scale and will remove megatons of carbon from the environment.”

      The primary metric that determines success is the cost of capture on a per-ton basis.

      “The world expects us to be able to capture at least 90% of the CO2 that’s being emitted in a stream and get it to a 95% concentration. We can do that, and we use those as our benchmarks for performance,” she says.

      The next step is putting more demonstrations into the field. Nemser remains tight-lipped about timing and locations beyond saying Optiperm can be quickly deployed anywhere.

      “We’re looking at a range of different applications in different industries, with the common denominator being that they all have flue gas streams,” she says. “Think of it like the furnace system in your house with a flue that releases the CO2 nitrogen mix out into the atmosphere.”

      Carbon Capture Technology in Delaware

      Nemser says Delaware is an excellent place for scientific research and development.

      “We’re doing cutting-edge work in climate technology,” she says. “Delaware’s history in chemicals has created a baseline and core competency. We’ve seen the evolution to clean chemicals, and now we’re seeing chemicals as energy, hydrogen fuels, solar power, electrolysis, and a variety of other chemical-based technologies. Delaware has a lot to contribute to the future of chemistry being the future of energy and clean energy, and the talent here is second to none in developing this.”

      When Nemser joined the company her father Stuart founded in 1993 after leaving DuPont, she started moving it from a domestic science-driven R&D lab to a global commercial organization that constantly generates new intellectual property.

      “I thought [our future] would be in petrochemicals and then broadly in industry and carbon capture but probably 10 years later than we’re seeing now,” she says. “In many ways, we see an acceleration in the interest in carbon capture.”

      Her father, Nemser says, “thinks it’s amazing that membranes are having their day in the sun. Dad’s vision was always that technologists needed to find a way to stop separations from being one of the largest energy hogs on the planet as they produce the products that we want and prevent them from creating the emissions profile that they now have.”

      Nemser says that modular systems like the CMS membrane can be used in both large plants like you see dotting the American landscape as well as new greenfield applications, and even small installations as the world moves towards more decentralized processes and plants.

      Nemser says she’s proud of what CMS has accomplished but concedes she always says, ‘let’s do it faster.’ I’m always looking ahead, not behind, at the next mountain to climb.”

      “It’s one thing to prove it out in a chemical plant, but the whole point is how do we expand these use cases so that we’re really talking about the next generation of deployments in carbon capture,” she says.

      Nemser says Braskem is only the launching point, adding it makes sense that a Delaware company is at the brink of innovation like this.

      “The future of chemicals is energy and a clean planet,” she says. “It’s not where we were. It’s where we’re going.”

      Newsletter Sign Up

      Stay Up To Date With Delaware

      Continue reading